Hospital/Health System

July 19, 2017

Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP

Pharmacists are in a key position to recommend de-escalation of antimicrobial therapy based on culture and sensitivity results and to ensure that patients are receiving the appropriate duration of therapy.
July 19, 2017

The Pharmacist’s Role in the Treatment and Prevention of Acute Mountain Sickness

Untreated, this condition, which is cased by travel to mountainous regions, can progress to high-altitude cerebral or pulmonary edema.
May 19, 2017

Hypophosphatasia: A Rare Disorder

Hypophosphatasia is a rare genetic metabolic disorder caused by mutations in the tissue nonspecific alkaline phosphatase gene (ALPL) that lead to defective mineralization of the bones and/or teeth.
May 19, 2017

Managing Lysosomal Acid Lipase Deficiency

When treating a complex genetic disorder like LAL-D, an interdisciplinary team approach can be beneficial and provides the best outcomes for patients.

April 21, 2017

Necrotizing Soft-Tissue Infection: Disease Overview and Updated Treatment Strategies

Necrotizing soft-tissue infections are a type of serious bacterial infection requiring rapid recognition and intervention in combination with timely antibiotic treatment.
April 21, 2017

Travel-Related Infection in Children: Pretravel Counseling to Reduce Morbidity

Travel-related infections affect children disproportionately and may lead to serious consequences; pharmacists can provide crucial pretravel information.
March 17, 2017

Treatment Options in Managing Acute Perioperative Pain

If the interventions and drugs employed perioperatively are inadequate, the pain could develop into a chronic problem or worsen patient outcomes.
March 17, 2017

Pearls and Pitfalls of Patient-Controlled Analgesia

Patient-controlled analgesia refers to the delivery of analgesics immediately upon patient demand.
February 16, 2017

Updated Treatment Options in the Management of Hyperkalemia

Patiromer was recently approved for chronic hyperkalemia, and other medications are in development.